Xuebin Wang

496 total citations
29 papers, 365 citations indexed

About

Xuebin Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Xuebin Wang has authored 29 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Oncology. Recurrent topics in Xuebin Wang's work include Cardiovascular Function and Risk Factors (3 papers), Folate and B Vitamins Research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Xuebin Wang is often cited by papers focused on Cardiovascular Function and Risk Factors (3 papers), Folate and B Vitamins Research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Xuebin Wang collaborates with scholars based in China, Taiwan and United States. Xuebin Wang's co-authors include Ning‐hua Cui, Changwei Liu, Leng Ni, Shuai Zhang, Xin Liu, Zhewei Zhao, Rong Zeng, Wen-Da Wang, Zhichao Lai and Liang Ming and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Xuebin Wang

29 papers receiving 363 citations

Peers

Countries citing papers authored by Xuebin Wang

Since Specialization

Citations

This map shows the geographic impact of Xuebin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuebin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuebin Wang more than expected).

Fields of papers citing papers by Xuebin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuebin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuebin Wang. The network helps show where Xuebin Wang may publish in the future.

Co-authorship network of co-authors of Xuebin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuebin Wang. A scholar is included among the top collaborators of Xuebin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuebin Wang. Xuebin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Per- and Polyfluoroalkyl Substances, Serum Lipidome, and Clinical Outcomes after Percutaneous Coronary Intervention in Type 2 Diabetic Patients: A Prospective Nested Case-control Study 2025 ·Journal of Atherosclerosis and Thrombosis ·(unknown), (unknown), Ning‐hua Cui, Bing Wang, (unknown), Xuebin Wang	1
2	Platelet bioenergetic profiling uncovers a metabolic pattern of high dependency on mitochondrial fatty acid oxidation in type 2 diabetic patients who developed in-stent restenosis 2024 ·Redox Biology ·Xuebin Wang, Ning‐hua Cui, (unknown), (unknown), (unknown)	6
3	First-in-human Implantation of a 3D-printing Fully Bioresorbable Drug Eluting Stent for Treatment of Superficial Femoral Artery Disease 2024 ·SHILAP Revista de lepidopterología ·(unknown), Xuebin Wang, Mingyuan Liu, Bin Liu, Zhong Chen, Xueming Chen, (unknown)	1
4	Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study 2024 ·International Journal of Clinical Pharmacy ·Xuebin Wang, (unknown), Jingxia Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Meiqing Feng	2
5	Identification of key mi RNA s in unilateral mastication‐induced disruption of cartilage homeostasis 2023 ·Oral Diseases ·Mengjie Wu, Xuebin Wang, Jing Shuai, (unknown), Haiping Lu, (unknown), (unknown), (unknown)	1
6	Inhibition of mitochondrial complex I leading to NAD+/NADH imbalance in type 2 diabetic patients who developed late stent thrombosis: Evidence from an integrative analysis of platelet bioenergetics and metabolomics 2022 ·Redox Biology ·(unknown), Ning‐hua Cui, Xianan Liu, Xuebin Wang	14
7	A novel 6-metabolite signature for prediction of clinical outcomes in type 2 diabetic patients undergoing percutaneous coronary intervention 2022 ·Cardiovascular Diabetology ·Xuebin Wang, Ning‐hua Cui, Xianan Liu	7
8	An indirect comparison by Bayesian network meta-analysis of drug-coated devices versus saphenous vein graft bypass in femoropopliteal arterial occlusive disease 2021 ·Journal of Vascular Surgery ·Rui Zhang, Leng Ni, Rong Zeng, Zhichao Lai, Di Xiao, Zhewei Zhao, Zhibo Xie, Xuebin Wang, Baitao Ma, Changwei Liu	2
9	Joint effects of mitochondrial DNA4977 deletion and serum folate deficiency on coronary artery disease in type 2 diabetes mellitus 2020 ·Clinical Nutrition ·Xuebin Wang, Ning‐hua Cui, (unknown), Xin Liu	6
10	Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients 2020 ·Journal of Vascular Surgery Venous and Lymphatic Disorders ·Rui Zhang, Leng Ni, Di Xiao, Xuebin Wang, Baitao Ma, Shuai Niu, Changwei Liu	26
11	Mitochondrial 8-hydroxy-2′-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus 2020 ·Cardiovascular Diabetology ·Xuebin Wang, Ning‐hua Cui, (unknown), Xin Liu	34
12	Leukocyte Mitochondrial DNA Copy Number and Risk of Thyroid Cancer: A Two-Stage Case-Control Study 2019 ·Frontiers in Endocrinology ·Jian Zheng, Ning‐hua Cui, Shuai Zhang, Xuebin Wang, Liang Ming	16
13	Validation and evaluation of a newly developed time-resolved fluoroimmunoassay for cyclosporine quantitative analysis in human whole blood 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·Xuebin Wang, Yuan Gao, Yunyun Yang, (unknown), (unknown), Fengbo Wu, (unknown), Xiaojian Xu, Zhuo Wang, Shusen Sun	3
14	Identification of a blood-based 12-gene signature that predicts the severity of coronary artery stenosis: An integrative approach based on gene network construction, Support Vector Machine algorithm, and multi-cohort validation 2019 ·Atherosclerosis ·Xuebin Wang, Ning‐hua Cui, (unknown), Liang Ming	4
15	PARP-1 Variant Rs1136410 Confers Protection against Coronary Artery Disease in a Chinese Han Population: A Two-Stage Case-Control Study Involving 5643 Subjects 2017 ·Frontiers in Physiology ·Xuebin Wang, Ning‐hua Cui, Shuai Zhang, Shuren Guo, Zejin Liu, Liang Ming	12
16	Association of BAFF with PI3K/Akt/mTOR signaling in lupus nephritis 2017 ·Molecular Medicine Reports ·(unknown), Fangfang Wang, (unknown), Li Zhao, Xuebin Wang	25
17	Associations of Polymorphisms in MTHFR Gene with the Risk of Age-Related Cataract in Chinese Han Population: A Genotype-Phenotype Analysis 2015 ·PLoS ONE ·Xuebin Wang, (unknown), (unknown), (unknown), Ning‐hua Cui, (unknown), (unknown), Fang Zheng, Ming Yan	8
18	SMN1 duplications contribute to sporadic amyotrophic lateral sclerosis susceptibility: Evidence from a meta-analysis 2014 ·Journal of the Neurological Sciences ·Xuebin Wang, Ning‐hua Cui, Jiajia Gao, Xueping Qiu, Fang Zheng	18
19	Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis 2014 ·PLoS ONE ·Xuebin Wang, Ning‐hua Cui, Jie Yang, Xueping Qiu, Jiajia Gao, Na Yang, Fang Zheng	12
20	Cimetidine attenuates vinorelbine-induced phlebitis in mice by militating E-selectin expression 2014 ·Cancer Chemotherapy and Pharmacology ·(unknown), Lijuan Ma, Xuebin Wang, (unknown), (unknown), Jiyong Liu, HU Jin-hong, Ding‐Feng Su	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact